1. Home
  2. PRAA vs LENZ Comparison

PRAA vs LENZ Comparison

Compare PRAA & LENZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo PRA Group Inc.

PRAA

PRA Group Inc.

HOLD

Current Price

$15.84

Market Cap

639.1M

Sector

Finance

ML Signal

HOLD

Logo LENZ Therapeutics Inc.

LENZ

LENZ Therapeutics Inc.

HOLD

Current Price

$19.84

Market Cap

609.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PRAA
LENZ
Founded
1996
2019
Country
United States
United States
Employees
N/A
N/A
Industry
Finance: Consumer Services
Medicinal Chemicals and Botanical Products
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
639.1M
609.5M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
PRAA
LENZ
Price
$15.84
$19.84
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
4
Target Price
$24.33
$56.25
AVG Volume (30 Days)
246.0K
1.1M
Earning Date
02-18-2026
03-18-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$1,161,679,000.00
$17,500,000.00
Revenue This Year
$7.85
N/A
Revenue Next Year
$7.40
$203.46
P/E Ratio
N/A
N/A
Revenue Growth
11.41
N/A
52 Week Low
$12.29
$14.43
52 Week High
$23.97
$50.40

Technical Indicators

Market Signals
Indicator
PRAA
LENZ
Relative Strength Index (RSI) 41.19 52.52
Support Level $15.71 $19.26
Resistance Level $17.27 $21.80
Average True Range (ATR) 0.59 1.46
MACD -0.14 0.75
Stochastic Oscillator 11.69 72.12

Price Performance

Historical Comparison
PRAA
LENZ

About PRAA PRA Group Inc.

PRA Group Inc is a leader in acquiring and collecting nonperforming loans. The company returns capital to banks and other creditors to help expand financial services for consumers in the Americas, Europe, and Australia. It is also engaged in providing fee-based services on class action claims recoveries in the United States. The company's portfolio segments include; Core, which is engaged in purchasing and collecting nonperforming loans, which the originators have not chosen not to pursue, and the Insolvency segment which is engaged in purchasing and collecting nonperforming loans where the customer is involved in a bankruptcy proceeding.

About LENZ LENZ Therapeutics Inc.

LENZ Therapeutics Inc is a late-stage biopharmaceutical company focused on developing and commercializing therapies to improve vision and developing ophthalmic pharmaceutical products.. Its initial focus is the treatment of presbyopia, the inevitable loss of near vision that impacts the daily lives of nearly all people over 45.

Share on Social Networks: